Timothy Eugene Sullivan - 01 Mar 2024 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Reporting relationship: Chief Financial Officer
Issuer ticker: APLS
Reported as of: 01 Mar 2024
Net transaction value: -$319,160
SEC form: 4
Accepted by SEC: 05 Mar 2024, 16:04:13 UTC
Prior SEC filing: 13 Feb 2024
Next SEC filing: 02 Apr 2024
Source filing: View source filing
Reporting owner signature: /s/s David Watson, attorney-in-fact for Timothy Sullivan

Key filing fact

Timothy Eugene Sullivan filed Form 4 for Apellis Pharmaceuticals, Inc. (APLS) on 05 Mar 2024.

Key facts

This page summarizes Timothy Eugene Sullivan's Form 4 filing for Apellis Pharmaceuticals, Inc. (APLS).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Mar 2024, 16:04.

Change

Previous filing in this sequence was filed on 13 Feb 2024.
Current net transaction value: -$319,160.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APLS transaction

Common Stock

Options Exercise

Transaction value: $60,180
Shares: +6,000
Change %: +6.4%
Price: $10.03^*
Shares after: 99,338
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

APLS transaction

Common Stock

Sale

Transaction value: $251,440
Shares: -4,000
Change %: -4%
Price: $62.86
Shares after: 95,338
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

APLS transaction

Common Stock

Sale

Transaction value: $127,900
Shares: -2,000
Change %: -2.1%
Price: $63.95
Shares after: 93,338
Date: 01 Mar 2024
Ownership: Direct
Footnotes: F2

APLS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 56,232
Date: 01 Mar 2024
Ownership: The Timothy E Sullivan Irrevocable Trust of 2023
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APLS transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value: $0
Shares: -6,000
Change %: -2.2%
Price: $0.000000
Shares after: 261,903
Date: 01 Mar 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 6,000
Exercise price: $10.03
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

The securities are held by The Timothy E Sullivan Irrevocable Trust of 2023. Patrick O. Collins is the trustee of The Timothy E Sullivan Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Timothy E Sullivan Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.

Footnote F2

This is a scheduled exercise & sale from 10b5-1 trading plan dated 12/1/23.

Footnote F3

This option was granted on October 18, 2017 and fully vested.